Skip to main content

Main menu

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
  • Other Publications
    • The Journal of Applied Laboratory Medicine

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
Clinical Chemistry
  • Other Publications
    • The Journal of Applied Laboratory Medicine
  • Subscribe
  • My alerts
  • Log in
Clinical Chemistry

Advanced Search

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
Article CommentaryClinical Case Study

Commentary

Bradley Ford
DOI: 10.1373/clinchem.2016.263558 Published February 2017
Bradley Ford
Department of Pathology, University of Iowa, Iowa City, IA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bradley-ford-1@uiowa.edu
  • Article
  • Info & Metrics
  • PDF
Loading

This very interesting report communicates a case of acquired HDL-C deficiency that is remarkable for its infectious origin. Very low or undetectable HDL-C more often originates from assay interference from paraproteins and autoantibodies or secondary to the use of drugs, including anabolic steroids and fibrates. Infectious diseases often induce several responses that may hypothetically reduce HDL-C concentrations; impairment of macrophage activity; a humoral immune response that cross-reacts with reagents in enzymatic HDL assays: inflammation mediated by cytokines that may specifically reduce HDL-C concentrations; and direct or indirect impairment of liver synthetic function. However, it is generally true that undetectable HDL-C is an unusual finding relative to the numbers of septic patients seen in most hospital settings and the patient in this case did not have laboratory findings consistent with acute or chronic liver failure.

This raises the possibility that Babesia directly reduces HDL-C in the course of its pathogenesis. Common parasites such as Toxoplasma gondii, Plasmodium falciparum and other Plasmodium spp., Cryptosporidium parvum, and nonhuman pathogens such as Theileria and Eimeria spp. actively acquire host cholesterol for synthesis of cell membranes and other structures and/or are strict auxotrophs for specific forms of cholesterol such as HDL-C and LDL-C. This underappreciated aspect of parasite pathogenesis has potential significance in humans as well as other animals such as dogs (which are commonly infected with Babesia and, in contrast to humans, have an abundance of HDL-C and very little LDL-C), cattle, and other animals in which lipid synthesis and scavenging pathways are potential therapeutic targets for pathogens that have relatively few treatments. This case invites further study through a larger case series and adds undetectable HDL-C to a list of laboratory findings that may telegraph the presence of otherwise difficult-to-diagnose infections.

Footnotes

  • Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article.

  • Authors' Disclosures or Potential Conflicts of Interest: No authors declared any potential conflicts of interest.

  • Received for publication November 14, 2016.
  • Accepted for publication November 22, 2016.
  • © 2016 American Association for Clinical Chemistry
View Abstract
PreviousNext
Back to top

In this issue

Clinical Chemistry: 63 (3)
Vol. 63, Issue 3
March 2017
  • Table of Contents
  • About the Cover
  • Index by author
  • Table of Contents (PDF)
  • Cover (PDF)
  • Advertising (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
  • Audio summary of this issue
Print
Share
Commentary
Bradley Ford
Clinical Chemistry Mar 2017, 63 (3) 645-646; DOI: 10.1373/clinchem.2016.263558
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Commentary
Bradley Ford
Clinical Chemistry Mar 2017, 63 (3) 645-646; DOI: 10.1373/clinchem.2016.263558

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Commentary
  • A Man with Recurrent Fractures and Foot Pain
  • Commentary
Show more Clinical Case Study

Similar Articles

Options

  • Home
  • About
  • Articles
  • Information for Authors
  • Resources
  • Abstracts
  • Submit
  • Contact
  • RSS

Other Publications

  • The Journal of Applied Laboratory Medicine
Footer logo

© 2018 American Association for Clinical Chemistry

Powered by HighWire